Brenda Mann Kiora Pharmaceuticals Inc (KPRX) insider trading activity

Brenda Mann is VP of Research & Development of KIORA PHARMACEUTICALS INC. Currently has a direct ownership of 15,136 shares of KPRX, which is worth approximately $49,494. The most recent transaction as insider was on Nov 02, 2021, when has been sold 62 shares (Common Stock) at a price of $1.98 per share, resulting in proceeds of $123. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.1K

0% 3M change

0% 12M change

Total Value Held $49,494

Brenda Mann Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 02 2021	SELL Payment of exercise price or tax liability	$123 $1.98 p/Share	62 Reduced 0.41%	15,136 Common Stock
Oct 04 2021	SELL Payment of exercise price or tax liability	$125 $2.01 p/Share	62 Reduced 0.41%	15,198 Common Stock
Sep 02 2021	SELL Payment of exercise price or tax liability	$110 $1.81 p/Share	61 Reduced 0.4%	15,260 Common Stock
Aug 03 2021	SELL Payment of exercise price or tax liability	$151 $2.4 p/Share	63 Reduced 0.41%	15,321 Common Stock
Jul 02 2021	SELL Payment of exercise price or tax liability	$570 $3.7 p/Share	154 Reduced 0.99%	15,384 Common Stock
Jun 04 2021	SELL Payment of exercise price or tax liability	$649 $4.19 p/Share	155 Reduced 0.99%	15,538 Common Stock
May 04 2021	SELL Payment of exercise price or tax liability	$789 $4.13 p/Share	191 Reduced 1.2%	15,693 Common Stock
Apr 08 2021	SELL Payment of exercise price or tax liability	$948 $4.94 p/Share	192 Reduced 1.19%	15,884 Common Stock
Mar 03 2021	SELL Payment of exercise price or tax liability	$1,048 $5.46 p/Share	192 Reduced 1.18%	16,076 Common Stock
Feb 02 2021	SELL Payment of exercise price or tax liability	$6,264 $6.34 p/Share	988 Reduced 5.73%	16,268 Common Stock
Jan 04 2021	SELL Payment of exercise price or tax liability	$558 $4.85 p/Share	115 Reduced 0.66%	17,256 Common Stock
Dec 07 2020	SELL Payment of exercise price or tax liability	$342 $3.76 p/Share	91 Reduced 0.52%	17,371 Common Stock
Nov 02 2020	SELL Payment of exercise price or tax liability	$337 $3.51 p/Share	96 Reduced 0.55%	17,462 Common Stock
Oct 02 2020	SELL Payment of exercise price or tax liability	$380 $3.88 p/Share	98 Reduced 0.56%	17,558 Common Stock

Brenda Mann

VP of Research & Development

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPRX shares.

Notify only if

Value

Insider Trading

Get notified when an Kiora Pharmaceuticals Inc insider buys or sells KPRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to KIORA PHARMACEUTICALS INC

Track Activities on KPRX

Account